Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis

Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis

Acute respiratory distress syndrome (ARDS) is a serious lung condition characterized by severe hypoxemia leading to limitations of oxygen needed for lung function. In this study, we investigated the effect of anandamide (AEA), an endogenous cannabinoid, on Staphylococcal enterotoxin B (SEB)-mediated...

Full description

Bibliographic Details
Main Authors: Muthanna Sultan, Kiesha Wilson, Osama A. Abdulla, Philip Brandon Busbee, Alina Hall, Taylor Carter, Narendra Singh, Saurabh Chatterjee, Prakash Nagarkatti, Mitzi Nagarkatti
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Cells
Subjects:
acute respiratory distress syndrome (ARDS)
Staphylococcus enterotoxin B (SEB)
anandamide (AEA)
COVID-19
microbiome
MiSeq sequencing
Online Access:https://www.mdpi.com/2073-4409/10/12/3305

Similar Items

Similar Items